A synthetic peptide for use as a blocking control in assays to test for specificity of NR4 A3 antibody, Alternative Names: NR4A3 control peptide, NR4A3 antibody Blocking Peptide, Anti-NR4A3 Blocking Peptide, Nuclear Receptor Subfamily 4 Group A Member 3 Blocking Peptide, CHN Blocking Peptide, CSMF Blocking Peptide, MINOR Blocking Peptide, NOR1 Blocking Peptide, TEC Blocking Peptide, NR4A3, NRA3-4, NRA3 4, NRA3-4 Blocking Peptide, NRA3 4 Blocking Peptide
NR4A3
Reaktivität: Human, Ratte, Affe, Schwein
Wirt: Synthetic
BP
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
NR4A3
(Nuclear Receptor Subfamily 4, Group A, Member 3 (NR4A3))
Synonyme
CHN Peptide, CSMF Peptide, MINOR Peptide, NOR1 Peptide, TEC Peptide, AI573420 Peptide, NOR-1 Peptide, Nor1 Peptide, NOR-2 Peptide, NR4A3 Peptide, Nr4a3 Peptide, nuclear receptor subfamily 4 group A member 3 Peptide, nuclear receptor subfamily 4, group A, member 3 Peptide, NR4A3 Peptide, Nr4a3 Peptide, nr4a3 Peptide
Hintergrund
NR4A3 is a member of the steroid-thyroid hormone-retinoid receptor superfamily. NR4A3 may act as a transcriptional activator. The protein can efficiently bind the NGFI-B Response Element (NBRE). Three different versions of extraskeletal myxoid chondrosarcomas (EMCs) are the result of reciprocal translocations between NR4A3 gene and other genes.